TY  - JOUR
AU  - Kalweit, Gabriel
AU  - Ullrich, Evelyn
AU  - Boedecker, Joschka
AU  - Mertelsmann, Roland
AU  - Kalweit, Maria
TI  - AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress.
JO  - Oxford open immunology
VL  - 6
IS  - 1
SN  - 2633-6960
CY  - Oxford
PB  - Oxford University Press
M1  - DKFZ-2025-01092
SP  - iqaf004
PY  - 2025
AB  - The molecular complexity of cancer presents significant challenges to traditional therapeutic approaches, necessitating the development of innovative treatment strategies capable of addressing the disease's dynamic nature and resistance mechanisms. Data-driven methodologies, particularly those employing Artificial Intelligence (AI), hold substantial promise by advancing a comprehensive understanding of the intricate molecular and cellular mechanisms underlying cancer and supporting the development of adaptive, patient-specific therapeutic strategies. Initiated through the Mertelsmann Foundation, the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg im Breisgau, Germany, aims to drive progress in AI-driven oncology. CRIION fosters global collaboration through initiatives like the Intelligent Oncology Symposium and supports multidisciplinary projects designed to integrate AI innovations into clinical workflows.
KW  - AI in oncology (Other)
KW  - interdisciplinary collaboration (Other)
KW  - optimized cancer treatment (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:40417176
C2  - pmc:PMC12103913
DO  - DOI:10.1093/oxfimm/iqaf004
UR  - https://inrepo02.dkfz.de/record/301584
ER  -